61.70
-1.77 (-2.79%)
| Previous Close | 63.47 |
| Open | 63.00 |
| Volume | 6,070,445 |
| Avg. Volume (3M) | 4,354,765 |
| Market Cap | 28,066,822,144 |
| Price / Earnings (TTM) | 14.80 |
| Price / Earnings (Forward) | 12.45 |
| Price / Sales | 1.33 |
| Price / Book | 2.60 |
| 52 Weeks Range | |
| Earnings Date | 29 Jul 2026 |
| TTM Dividend Yield | 0.23% |
| Profit Margin | 11.03% |
| Operating Margin (TTM) | 14.78% |
| Diluted EPS (TTM) | 4.76 |
| Quarterly Revenue Growth (YOY) | 2.70% |
| Quarterly Earnings Growth (YOY) | 50.80% |
| Total Debt/Equity (MRQ) | 97.51% |
| Current Ratio (MRQ) | 0.980 |
| Operating Cash Flow (TTM) | 1.78 B |
| Levered Free Cash Flow (TTM) | 1.58 B |
| Return on Assets (TTM) | 5.87% |
| Return on Equity (TTM) | 26.44% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | GE HealthCare Technologies Inc. | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 3.5 |
| Insider Activity | 3.5 |
| Price Volatility | 5.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -2.5 |
| Average | 2.10 |
|
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%). |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Core |
| % Held by Insiders | 0.28% |
| % Held by Institutions | 80.26% |
| 52 Weeks Range | ||
| Median | 84.00 (36.14%) | |
| Total | 1 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 11 Mar 2026 | 84.00 (36.14%) | Hold | 72.65 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CULP H LAWRENCE JR | 61.74 | - | 80,805 | 4,988,497 |
| STROMBERG WILLIAM J | 61.74 | - | 1,000 | 61,735 |
| Aggregate Net Quantity | 81,805 | |||
| Aggregate Net Value ($) | 5,050,232 | |||
| Aggregate Avg. Buy ($) | 61.74 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| STROMBERG WILLIAM J | Director | 06 May 2026 | Buy (+) | 1,000 | 61.74 | 61,735 |
| CULP H LAWRENCE JR | Director | 06 May 2026 | Buy (+) | 80,805 | 61.74 | 4,988,497 |
| TTM Dividend Yield | 0.23% |
| 3Y Average Dividend Yield | 0.15% |
| Payout Ratio | 2.63% |
| Expected Next Dividend Payment | Aug 2026 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 02 Apr 2026 | 12 Feb 2026 | 15 May 2026 | 0.035 Cash |
| 09 Jan 2026 | 24 Nov 2025 | 13 Feb 2026 | 0.035 Cash |
| 24 Oct 2025 | 24 Sep 2025 | 14 Nov 2025 | 0.035 Cash |
| 25 Jul 2025 | 01 Jul 2025 | 15 Aug 2025 | 0.035 Cash |
| 25 Apr 2025 | 27 Mar 2025 | 15 May 2025 | 0.035 Cash |
| 14 Jan 2025 | 21 Nov 2024 | 14 Feb 2025 | 0.035 Cash |
| 18 Oct 2024 | 18 Sep 2024 | 15 Nov 2024 | 0.03 Cash |
| 19 Jul 2024 | 26 Jun 2024 | 15 Aug 2024 | 0.03 Cash |
| 18 Apr 2024 | 22 Mar 2024 | 15 May 2024 | 0.03 Cash |
| 12 Jan 2024 | 08 Dec 2023 | 15 Feb 2024 | 0.03 Cash |
| 19 Oct 2023 | 22 Sep 2023 | 15 Nov 2023 | 0.03 Cash |
| 20 Jul 2023 | 23 Jun 2023 | 15 Aug 2023 | 0.03 Cash |
| 22 May 2023 | 25 Apr 2023 | 15 Jun 2023 | 0.03 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2026 | 0.070 | 2 | 0.11 |
| 2025 | 0.140 | 4 | 0.17 |
| 2024 | 0.120 | 4 | 0.15 |
| 2023 | 0.090 | 3 | 0.12 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |